The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hospital and Nursing Home Probiotics Market Research Report 2024

Global Hospital and Nursing Home Probiotics Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1890522

No of Pages : 92

Synopsis
Probiotics are live microorganisms intended to provide health benefits when consumed, generally by improving or restoring the gut flora.
The global Hospital and Nursing Home Probiotics market was valued at US$ 70 million in 2023 and is anticipated to reach US$ 92 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital and Nursing Home Probiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital and Nursing Home Probiotics.
Report Scope
The Hospital and Nursing Home Probiotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital and Nursing Home Probiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital and Nursing Home Probiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio - K Plus International
American Lifeline
Rising Pharmaceuticals
Becton Dickinson and Company
NutraScience Labs
Vitakem Nutraceuticals
Probium
Protexin
Nutraceutix
Nebraska Cultures
Mercola
Eva Nutra
UP4 Probiotics
Segment by Type
Lactobacillus
Bifidobacterium
Gram-positive Cocci
Others
Segment by Application
Gut Health
Immunity
Wellness
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hospital and Nursing Home Probiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hospital and Nursing Home Probiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Hospital and Nursing Home Probiotics Market Overview
1.1 Product Overview and Scope of Hospital and Nursing Home Probiotics
1.2 Hospital and Nursing Home Probiotics Segment by Type
1.2.1 Global Hospital and Nursing Home Probiotics Market Value Comparison by Type (2024-2030)
1.2.2 Lactobacillus
1.2.3 Bifidobacterium
1.2.4 Gram-positive Cocci
1.2.5 Others
1.3 Hospital and Nursing Home Probiotics Segment by Application
1.3.1 Global Hospital and Nursing Home Probiotics Market Value by Application: (2024-2030)
1.3.2 Gut Health
1.3.3 Immunity
1.3.4 Wellness
1.3.5 Others
1.4 Global Hospital and Nursing Home Probiotics Market Size Estimates and Forecasts
1.4.1 Global Hospital and Nursing Home Probiotics Revenue 2019-2030
1.4.2 Global Hospital and Nursing Home Probiotics Sales 2019-2030
1.4.3 Global Hospital and Nursing Home Probiotics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hospital and Nursing Home Probiotics Market Competition by Manufacturers
2.1 Global Hospital and Nursing Home Probiotics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hospital and Nursing Home Probiotics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hospital and Nursing Home Probiotics Average Price by Manufacturers (2019-2024)
2.4 Global Hospital and Nursing Home Probiotics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hospital and Nursing Home Probiotics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hospital and Nursing Home Probiotics, Product Type & Application
2.7 Hospital and Nursing Home Probiotics Market Competitive Situation and Trends
2.7.1 Hospital and Nursing Home Probiotics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hospital and Nursing Home Probiotics Players Market Share by Revenue
2.7.3 Global Hospital and Nursing Home Probiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hospital and Nursing Home Probiotics Retrospective Market Scenario by Region
3.1 Global Hospital and Nursing Home Probiotics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hospital and Nursing Home Probiotics Global Hospital and Nursing Home Probiotics Sales by Region: 2019-2030
3.2.1 Global Hospital and Nursing Home Probiotics Sales by Region: 2019-2024
3.2.2 Global Hospital and Nursing Home Probiotics Sales by Region: 2025-2030
3.3 Global Hospital and Nursing Home Probiotics Global Hospital and Nursing Home Probiotics Revenue by Region: 2019-2030
3.3.1 Global Hospital and Nursing Home Probiotics Revenue by Region: 2019-2024
3.3.2 Global Hospital and Nursing Home Probiotics Revenue by Region: 2025-2030
3.4 North America Hospital and Nursing Home Probiotics Market Facts & Figures by Country
3.4.1 North America Hospital and Nursing Home Probiotics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hospital and Nursing Home Probiotics Sales by Country (2019-2030)
3.4.3 North America Hospital and Nursing Home Probiotics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hospital and Nursing Home Probiotics Market Facts & Figures by Country
3.5.1 Europe Hospital and Nursing Home Probiotics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hospital and Nursing Home Probiotics Sales by Country (2019-2030)
3.5.3 Europe Hospital and Nursing Home Probiotics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hospital and Nursing Home Probiotics Market Facts & Figures by Country
3.6.1 Asia Pacific Hospital and Nursing Home Probiotics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hospital and Nursing Home Probiotics Sales by Country (2019-2030)
3.6.3 Asia Pacific Hospital and Nursing Home Probiotics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hospital and Nursing Home Probiotics Market Facts & Figures by Country
3.7.1 Latin America Hospital and Nursing Home Probiotics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hospital and Nursing Home Probiotics Sales by Country (2019-2030)
3.7.3 Latin America Hospital and Nursing Home Probiotics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hospital and Nursing Home Probiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Hospital and Nursing Home Probiotics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hospital and Nursing Home Probiotics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hospital and Nursing Home Probiotics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hospital and Nursing Home Probiotics Sales by Type (2019-2030)
4.1.1 Global Hospital and Nursing Home Probiotics Sales by Type (2019-2024)
4.1.2 Global Hospital and Nursing Home Probiotics Sales by Type (2025-2030)
4.1.3 Global Hospital and Nursing Home Probiotics Sales Market Share by Type (2019-2030)
4.2 Global Hospital and Nursing Home Probiotics Revenue by Type (2019-2030)
4.2.1 Global Hospital and Nursing Home Probiotics Revenue by Type (2019-2024)
4.2.2 Global Hospital and Nursing Home Probiotics Revenue by Type (2025-2030)
4.2.3 Global Hospital and Nursing Home Probiotics Revenue Market Share by Type (2019-2030)
4.3 Global Hospital and Nursing Home Probiotics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hospital and Nursing Home Probiotics Sales by Application (2019-2030)
5.1.1 Global Hospital and Nursing Home Probiotics Sales by Application (2019-2024)
5.1.2 Global Hospital and Nursing Home Probiotics Sales by Application (2025-2030)
5.1.3 Global Hospital and Nursing Home Probiotics Sales Market Share by Application (2019-2030)
5.2 Global Hospital and Nursing Home Probiotics Revenue by Application (2019-2030)
5.2.1 Global Hospital and Nursing Home Probiotics Revenue by Application (2019-2024)
5.2.2 Global Hospital and Nursing Home Probiotics Revenue by Application (2025-2030)
5.2.3 Global Hospital and Nursing Home Probiotics Revenue Market Share by Application (2019-2030)
5.3 Global Hospital and Nursing Home Probiotics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bio - K Plus International
6.1.1 Bio - K Plus International Corporation Information
6.1.2 Bio - K Plus International Description and Business Overview
6.1.3 Bio - K Plus International Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bio - K Plus International Hospital and Nursing Home Probiotics Product Portfolio
6.1.5 Bio - K Plus International Recent Developments/Updates
6.2 American Lifeline
6.2.1 American Lifeline Corporation Information
6.2.2 American Lifeline Description and Business Overview
6.2.3 American Lifeline Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 American Lifeline Hospital and Nursing Home Probiotics Product Portfolio
6.2.5 American Lifeline Recent Developments/Updates
6.3 Rising Pharmaceuticals
6.3.1 Rising Pharmaceuticals Corporation Information
6.3.2 Rising Pharmaceuticals Description and Business Overview
6.3.3 Rising Pharmaceuticals Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Rising Pharmaceuticals Hospital and Nursing Home Probiotics Product Portfolio
6.3.5 Rising Pharmaceuticals Recent Developments/Updates
6.4 Becton Dickinson and Company
6.4.1 Becton Dickinson and Company Corporation Information
6.4.2 Becton Dickinson and Company Description and Business Overview
6.4.3 Becton Dickinson and Company Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Becton Dickinson and Company Hospital and Nursing Home Probiotics Product Portfolio
6.4.5 Becton Dickinson and Company Recent Developments/Updates
6.5 NutraScience Labs
6.5.1 NutraScience Labs Corporation Information
6.5.2 NutraScience Labs Description and Business Overview
6.5.3 NutraScience Labs Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 NutraScience Labs Hospital and Nursing Home Probiotics Product Portfolio
6.5.5 NutraScience Labs Recent Developments/Updates
6.6 Vitakem Nutraceuticals
6.6.1 Vitakem Nutraceuticals Corporation Information
6.6.2 Vitakem Nutraceuticals Description and Business Overview
6.6.3 Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Vitakem Nutraceuticals Hospital and Nursing Home Probiotics Product Portfolio
6.6.5 Vitakem Nutraceuticals Recent Developments/Updates
6.7 Probium
6.6.1 Probium Corporation Information
6.6.2 Probium Description and Business Overview
6.6.3 Probium Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Probium Hospital and Nursing Home Probiotics Product Portfolio
6.7.5 Probium Recent Developments/Updates
6.8 Protexin
6.8.1 Protexin Corporation Information
6.8.2 Protexin Description and Business Overview
6.8.3 Protexin Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Protexin Hospital and Nursing Home Probiotics Product Portfolio
6.8.5 Protexin Recent Developments/Updates
6.9 Nutraceutix
6.9.1 Nutraceutix Corporation Information
6.9.2 Nutraceutix Description and Business Overview
6.9.3 Nutraceutix Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nutraceutix Hospital and Nursing Home Probiotics Product Portfolio
6.9.5 Nutraceutix Recent Developments/Updates
6.10 Nebraska Cultures
6.10.1 Nebraska Cultures Corporation Information
6.10.2 Nebraska Cultures Description and Business Overview
6.10.3 Nebraska Cultures Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nebraska Cultures Hospital and Nursing Home Probiotics Product Portfolio
6.10.5 Nebraska Cultures Recent Developments/Updates
6.11 Mercola
6.11.1 Mercola Corporation Information
6.11.2 Mercola Hospital and Nursing Home Probiotics Description and Business Overview
6.11.3 Mercola Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mercola Hospital and Nursing Home Probiotics Product Portfolio
6.11.5 Mercola Recent Developments/Updates
6.12 Eva Nutra
6.12.1 Eva Nutra Corporation Information
6.12.2 Eva Nutra Hospital and Nursing Home Probiotics Description and Business Overview
6.12.3 Eva Nutra Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Eva Nutra Hospital and Nursing Home Probiotics Product Portfolio
6.12.5 Eva Nutra Recent Developments/Updates
6.13 UP4 Probiotics
6.13.1 UP4 Probiotics Corporation Information
6.13.2 UP4 Probiotics Hospital and Nursing Home Probiotics Description and Business Overview
6.13.3 UP4 Probiotics Hospital and Nursing Home Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.13.4 UP4 Probiotics Hospital and Nursing Home Probiotics Product Portfolio
6.13.5 UP4 Probiotics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hospital and Nursing Home Probiotics Industry Chain Analysis
7.2 Hospital and Nursing Home Probiotics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hospital and Nursing Home Probiotics Production Mode & Process
7.4 Hospital and Nursing Home Probiotics Sales and Marketing
7.4.1 Hospital and Nursing Home Probiotics Sales Channels
7.4.2 Hospital and Nursing Home Probiotics Distributors
7.5 Hospital and Nursing Home Probiotics Customers
8 Hospital and Nursing Home Probiotics Market Dynamics
8.1 Hospital and Nursing Home Probiotics Industry Trends
8.2 Hospital and Nursing Home Probiotics Market Drivers
8.3 Hospital and Nursing Home Probiotics Market Challenges
8.4 Hospital and Nursing Home Probiotics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’